| Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
| contig09401 |
---NA--- |
223 |
0 |
|
|
0 |
|
|
|
| contig09402 |
---NA--- |
437 |
0 |
|
|
0 |
|
|
|
| contig09403 |
---NA--- |
341 |
0 |
|
|
0 |
|
|
|
| contig09404 |
---NA--- |
328 |
0 |
|
|
0 |
|
|
|
| contig09405 |
---NA--- |
680 |
0 |
|
|
0 |
|
|
|
| contig09406 |
---NA--- |
129 |
0 |
|
|
0 |
|
|
|
| contig09407 |
---NA--- |
235 |
0 |
|
|
0 |
|
|
|
| contig09408 |
---NA--- |
359 |
0 |
|
|
0 |
|
|
|
| contig09409 |
wd repeat domain 46 |
105 |
7 |
4.99E-09 |
89.71% |
4 |
C:cytoplasm; F:aminoacyl-tRNA ligase activity; F:ATP binding; P:tRNA aminoacylation for protein translation |
|
|
| contig09410 |
catenin (cadherin-associated protein) beta 88kda |
1780 |
20 |
0 |
99.00% |
74 |
C:cytoskeleton; F:signal transducer activity; C:dendritic shaft; C:fascia adherens; P:ectoderm development; P:pancreas development; P:negative regulation of osteoclast differentiation; P:camera-type eye morphogenesis; P:apoptosis; F:alpha-catenin binding; P:positive regulation of epithelial cell differentiation; P:myoblast differentiation; P:androgen receptor signaling pathway; P:cell-matrix adhesion; F:protein C-terminus binding; P:midgut development; P:cell fate determination; F:double-stranded DNA binding; P:positive regulation of osteoblast differentiation; P:heart development; P:synaptic transmission; P:dorsal/ventral axis specification; P:synaptic vesicle transport; C:desmosome; F:structural molecule activity; P:cell-cell adhesion; P:cell fate specification; C:lamellipodium; C:cytosol; C:basolateral plasma membrane; P:forebrain development; P:endodermal cell fate commitment; P:liver development; P:Wnt receptor signaling pathway through beta-catenin; P:negative regulation of chondrocyte differentiation; P:epithelial to mesenchymal transition; C:catenin complex; P:cell morphogenesis involved in differentiation; F:transcription coactivator activity; P:positive regulation of transcription from RNA polymerase II promoter; P:regulation of cell proliferation; P:gastrulation with mouth forming second; P:embryonic digit morphogenesis; F:androgen receptor binding; P:synapse organization; C:microvillus membrane; C:transcription factor complex; P:endoderm formation; P:negative regulation of transcription from RNA polymerase II promoter; P:response to estrogen stimulus; F:chromatin binding; P:patterning of blood vessels; F:transcription factor activity; P:embryonic axis specification; P:odontogenesis of dentine-containing tooth; C:synapse; P:bone resorption; P:morphogenesis of embryonic epithelium; F:cadherin binding; P:proximal/distal pattern formation; P:response to cadmium ion; C:apical part of cell; P:embryonic hindlimb morphogenesis; C:beta-catenin destruction complex; P:Schwann cell proliferation; C:Z disc; P:response to cytokine stimulus; P:embryonic arm morphogenesis; C:membrane fraction; P:cell maturation; C:cell cortex; P:response to organic cyclic substance; P:lung development; C:lateral plasma membrane |
|
|
| contig09411 |
nucleoporin 35kda |
901 |
20 |
4.89E-92 |
76.10% |
2 |
C:nucleus; P:protein transport |
|
|
| contig09412 |
dead (asp-glu-ala-as) box polypeptide 19a |
2082 |
20 |
0 |
84.85% |
8 |
F:RNA binding; F:ATP-dependent helicase activity; C:nuclear pore; F:ATP binding; F:protein binding; P:mRNA export from nucleus; P:intracellular protein transmembrane transport; C:cytoplasm |
|
|
| contig09413 |
nuclear distribution gene c homolog |
1454 |
20 |
1.99E-124 |
82.00% |
8 |
C:cytoplasm; P:cell proliferation; F:protein binding; P:multicellular organismal development; P:mitosis; C:nucleus; P:cell division; C:microtubule |
|
|
| contig09414 |
sry-box containing gene 11 |
729 |
20 |
5.55E-63 |
77.35% |
4 |
C:chromatin; F:DNA binding; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
| contig09415 |
cathepsin d |
1718 |
20 |
0 |
79.60% |
5 |
C:lysosome; P:proteolysis; F:pepsin A activity; F:endopeptidase inhibitor activity; F:cathepsin D activity |
EC:3.4.23.1; EC:3.4.23.5 |
|
| contig09416 |
---NA--- |
161 |
0 |
|
|
0 |
|
|
|
| contig09417 |
---NA--- |
166 |
0 |
|
|
0 |
|
|
|
| contig09418 |
wd repeat domain 77 |
1496 |
20 |
1.92E-146 |
72.55% |
4 |
F:binding; F:receptor activity; P:P; C:C |
|
|
| contig09419 |
translocase of outer mitochondrial membrane 40 |
889 |
20 |
2.42E-136 |
84.30% |
5 |
P:protein targeting to mitochondrion; P:anion transport; F:voltage-gated anion channel activity; C:integral to membrane; C:mitochondrial outer membrane |
|
|
| contig09420 |
PREDICTED: similar to KIAA1712 [Sus scrofa] |
518 |
3 |
2.49E-04 |
61.33% |
0 |
|
|
|
| contig09421 |
ring finger protein 219 |
1271 |
18 |
5.12E-17 |
45.06% |
3 |
F:metal ion binding; F:zinc ion binding; F:protein binding |
|
|
| contig09422 |
chromosome 1 open reading frame 149 |
1022 |
20 |
8.42E-86 |
87.35% |
2 |
P:P; C:C |
|
|
| contig09423 |
ubiquitin-activating enzyme e1 |
1689 |
20 |
0 |
90.00% |
6 |
F:ligase activity; F:ubiquitin activating enzyme activity; F:protein binding; P:ubiquitin-dependent protein catabolic process; P:ubiquitin cycle; F:ATP binding |
|
|
| contig09424 |
---NA--- |
533 |
0 |
|
|
0 |
|
|
|
| contig09425 |
protein disulfide isomerase family member 4 |
1475 |
20 |
0 |
77.65% |
6 |
C:endoplasmic reticulum lumen; P:cell redox homeostasis; F:protein binding; F:calcium ion binding; F:isomerase activity; P:protein secretion |
|
|
| contig09426 |
dead (asp-glu-ala-asp) box polypeptide 39 |
1434 |
20 |
0 |
98.05% |
7 |
F:ATP-dependent helicase activity; P:mRNA export from nucleus; F:nucleic acid binding; F:protein binding; F:ATP binding; C:nucleus; P:nuclear mRNA splicing, via spliceosome |
|
|
| contig09427 |
reticulon 4 |
315 |
20 |
3.30E-37 |
88.90% |
9 |
P:angiogenesis; C:integral to endoplasmic reticulum membrane; P:negative regulation of axon extension; C:neuronal cell body; P:regulation of cell migration; C:cell projection; P:negative regulation of anti-apoptosis; F:protein binding; C:nuclear envelope |
|
|
| contig09428 |
---NA--- |
106 |
0 |
|
|
0 |
|
|
|
| contig09429 |
---NA--- |
161 |
0 |
|
|
0 |
|
|
|
| contig09430 |
vesicle amine transport protein 1 |
1060 |
20 |
1.28E-92 |
84.45% |
7 |
F:heme binding; F:ATPase activity; P:metabolic process; F:peroxidase activity; F:cofactor binding; F:zinc ion binding; P:response to oxidative stress |
EC:1.11.1.7 |
|
| contig09431 |
---NA--- |
283 |
0 |
|
|
0 |
|
|
|
| contig09432 |
---NA--- |
597 |
0 |
|
|
0 |
|
|
|
| contig09433 |
uncharacterized protein c12orf29 |
1332 |
20 |
1.64E-154 |
76.15% |
2 |
P:P; C:C |
|
|
| contig09434 |
alcohol dehydrogenase class-3 |
1123 |
20 |
4.59E-112 |
93.95% |
6 |
P:metabolic process; C:cytoplasm; F:alcohol dehydrogenase (NAD) activity; P:zinc ion transport; F:S-(hydroxymethyl)glutathione dehydrogenase activity; F:zinc ion binding |
EC:1.1.1.1; EC:1.1.1.284 |
|
| contig09435 |
zona pellucida c |
562 |
20 |
1.56E-19 |
52.25% |
8 |
P:binding of sperm to zona pellucida; P:single fertilization; C:integral to membrane; C:proteinaceous extracellular matrix; F:acrosin binding; F:protein binding; C:extracellular region; C:plasma membrane |
|
|
| contig09436 |
zona pellucida glycoprotein 3 (sperm receptor) |
366 |
20 |
4.65E-12 |
55.40% |
1 |
F:acrosin binding |
|
|
| contig09437 |
---NA--- |
222 |
0 |
|
|
0 |
|
|
|
| contig09438 |
pdgfa associated protein 1 |
1913 |
20 |
2.13E-39 |
78.45% |
3 |
F:kinase activity; F:platelet-derived growth factor binding; P:platelet-derived growth factor receptor signaling pathway |
|
|
| contig09439 |
cdc28 protein kinase regulatory subunit 1b |
392 |
20 |
2.90E-38 |
93.25% |
6 |
F:kinase activity; P:regulation of cyclin-dependent protein kinase activity; F:cyclin-dependent protein kinase regulator activity; F:protein binding; P:cell division; P:cell proliferation |
|
|
| contig09440 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
| contig09441 |
transcription elongation factor a 1 |
765 |
20 |
4.21E-64 |
84.00% |
10 |
F:translation elongation factor activity; P:RNA elongation; F:zinc ion binding; P:positive regulation of transcription from RNA polymerase II promoter; F:DNA binding; P:erythrocyte differentiation; F:protein binding; F:transcription elongation regulator activity; C:nucleoplasm; F:RNA polymerase II transcription factor activity |
|
|
| contig09442 |
sft2 domain containing 2 |
693 |
20 |
1.70E-63 |
77.10% |
2 |
P:transport; C:membrane |
|
|
| contig09443 |
---NA--- |
441 |
0 |
|
|
0 |
|
|
|
| contig09444 |
succinate dehydrogenase subunit flavoprotein |
1267 |
20 |
7.36E-133 |
89.85% |
6 |
C:mitochondrial inner membrane; P:electron transport; P:transport; P:tricarboxylic acid cycle; F:FAD binding; F:succinate dehydrogenase (ubiquinone) activity |
EC:1.3.5.1 |
|
| contig09445 |
coiled-coil domain containing 22 |
376 |
20 |
8.35E-25 |
90.05% |
2 |
P:P; C:C |
|
|
| contig09446 |
utp11- u3 small nucleolar ribonucleoprotein |
376 |
20 |
1.74E-14 |
87.70% |
8 |
C:small-subunit processome; P:induction of apoptosis; P:rRNA processing; C:extracellular space; P:nerve growth factor receptor signaling pathway; P:nervous system development; F:protein binding; C:cytoplasm |
|
|
| contig09447 |
---NA--- |
847 |
0 |
|
|
0 |
|
|
|
| contig09448 |
---NA--- |
195 |
0 |
|
|
0 |
|
|
|
| contig09449 |
thyroid hormone receptor interactor 3 |
614 |
20 |
9.51E-67 |
67.50% |
2 |
F:thyroid hormone receptor binding; P:regulation of transcription, DNA-dependent |
|
|
| contig09450 |
sporulation meiosis- spo11 homolog ( cerevisiae) |
1246 |
20 |
3.47E-154 |
83.05% |
10 |
P:reciprocal meiotic recombination; P:female gamete generation; P:spermatogenesis; P:ovarian follicle development; F:ATP binding; F:DNA topoisomerase (ATP-hydrolyzing) activity; C:chromosome; P:DNA topological change; F:hydrolase activity; C:nucleus |
EC:5.99.1.3 |
|
| contig09451 |
---NA--- |
213 |
0 |
|
|
0 |
|
|
|
| contig09452 |
PREDICTED: similar to ReO_6 [Danio rerio] |
636 |
1 |
7.67E-09 |
65.00% |
0 |
|
|
|
| contig09453 |
---NA--- |
246 |
0 |
|
|
0 |
|
|
|
| contig09454 |
histone cluster h2bb |
173 |
20 |
5.18E-11 |
100.00% |
4 |
C:nucleosome; F:DNA binding; P:nucleosome assembly; C:nucleus |
|
|
| contig09455 |
---NA--- |
228 |
0 |
|
|
0 |
|
|
|
| contig09456 |
adenylate kinase |
684 |
2 |
2.72E-05 |
60.00% |
0 |
|
|
|
| contig09457 |
transducer of 1 |
759 |
20 |
1.35E-22 |
89.35% |
11 |
P:SMAD protein nuclear translocation; P:negative regulation of BMP signaling pathway; P:Wnt receptor signaling pathway through beta-catenin; F:SH3/SH2 adaptor activity; P:dorsal/ventral pattern formation; P:negative regulation of osteoblast differentiation; F:SMAD binding; P:negative regulation of cell proliferation; F:transcription corepressor activity; C:cytoplasm; C:nucleus |
|
|
| contig09458 |
transducer of 1 |
797 |
20 |
1.95E-107 |
91.70% |
11 |
P:SMAD protein nuclear translocation; P:negative regulation of BMP signaling pathway; P:Wnt receptor signaling pathway through beta-catenin; F:SH3/SH2 adaptor activity; P:dorsal/ventral pattern formation; P:negative regulation of osteoblast differentiation; F:SMAD binding; P:negative regulation of cell proliferation; F:transcription corepressor activity; C:cytoplasm; C:nucleus |
|
|
| contig09459 |
unnamed protein product [Tetraodon nigroviridis] |
459 |
1 |
1.34E-07 |
62.00% |
0 |
|
|
|
| contig09460 |
fk506 binding protein 25kda |
986 |
20 |
1.81E-114 |
87.95% |
5 |
P:protein folding; F:receptor activity; F:peptidyl-prolyl cis-trans isomerase activity; C:nucleus; F:FK506 binding |
EC:5.2.1.8 |
|
| contig09461 |
myristoylated alanine-rich protein kinase c substrate |
1691 |
20 |
1.77E-34 |
60.10% |
2 |
C:cytoskeleton; F:actin binding |
|
|
| contig09462 |
tumor suppressor candidate 2 |
1203 |
20 |
5.58E-42 |
86.10% |
4 |
P:cell-cell signaling; P:negative regulation of cell cycle; F:protein binding; P:cell proliferation |
|
|
| contig09463 |
---NA--- |
138 |
0 |
|
|
0 |
|
|
|
| contig09464 |
ribosomal protein s23 |
527 |
20 |
8.02E-14 |
99.40% |
5 |
F:translation regulator activity; F:structural constituent of ribosome; F:RNA binding; C:cytosolic small ribosomal subunit; P:translation |
EC:3.6.5.3 |
|
| contig09465 |
cytochrome c subunit viia 2 |
551 |
20 |
5.16E-33 |
80.85% |
5 |
F:electron carrier activity; P:electron transport; C:integral to membrane; F:cytochrome-c oxidase activity; C:mitochondrial respiratory chain |
EC:1.9.3.1 |
|
| contig09466 |
taf6 rna polymerase tata box binding protein -associated factor |
1222 |
20 |
9.20E-106 |
81.35% |
9 |
F:general RNA polymerase II transcription factor activity; F:DNA binding; F:protein binding; C:transcription factor TFIID complex; F:transcription initiation factor activity; P:transcription initiation; P:regulation of transcription factor activity; C:transcription factor TFIIE complex; P:regulation of transcription, DNA-dependent |
|
|
| contig09467 |
---NA--- |
111 |
0 |
|
|
0 |
|
|
|
| contig09468 |
deoxythymidylate kinase (thymidylate kinase) |
983 |
20 |
4.66E-79 |
76.70% |
6 |
F:thymidylate kinase activity; P:cell proliferation; P:dTDP biosynthetic process; P:cell cycle; P:dTTP biosynthetic process; F:nucleotide binding |
EC:2.7.4.9 |
|
| contig09469 |
---NA--- |
100 |
0 |
|
|
0 |
|
|
|
| contig09470 |
---NA--- |
156 |
0 |
|
|
0 |
|
|
|
| contig09471 |
---NA--- |
325 |
0 |
|
|
0 |
|
|
|
| contig09472 |
propionyl-coenzyme a alpha polypeptide |
1441 |
20 |
0 |
87.20% |
7 |
F:propionyl-CoA carboxylase activity; P:cellular amino acid catabolic process; P:fatty acid catabolic process; F:biotin binding; F:ATP binding; P:biotin biosynthetic process; C:mitochondrial matrix |
EC:6.4.1.3 |
|
| contig09473 |
rna binding motif protein 13 |
1864 |
20 |
2.48E-117 |
85.05% |
1 |
C:nucleus |
|
|
| contig09474 |
---NA--- |
170 |
0 |
|
|
0 |
|
|
|
| contig09475 |
proteasome ( macropain) 26s non- 1 |
697 |
20 |
3.39E-27 |
94.25% |
3 |
C:proteasome regulatory particle; F:protein binding; C:cytosol |
|
|
| contig09476 |
---NA--- |
306 |
0 |
|
|
0 |
|
|
|
| contig09477 |
ran binding protein 3 |
330 |
20 |
8.49E-46 |
76.75% |
1 |
P:intracellular transport |
|
|
| contig09478 |
---NA--- |
165 |
0 |
|
|
0 |
|
|
|
| contig09479 |
rab interacting factor |
641 |
20 |
1.10E-63 |
84.10% |
5 |
P:protein transport; F:guanyl-nucleotide exchange factor activity; F:zinc ion binding; P:cellular membrane fusion; P:small GTPase mediated signal transduction |
|
|
| contig09480 |
---NA--- |
249 |
0 |
|
|
0 |
|
|
|
| contig09481 |
---NA--- |
358 |
0 |
|
|
0 |
|
|
|
| contig09482 |
---NA--- |
718 |
0 |
|
|
0 |
|
|
|
| contig09483 |
mediator complex subunit 22 |
178 |
20 |
6.71E-19 |
95.80% |
3 |
; P:transcription antitermination; P:regulation of transcription, DNA-dependent |
|
|
| contig09484 |
---NA--- |
117 |
0 |
|
|
0 |
|
|
|
| contig09485 |
---NA--- |
493 |
0 |
|
|
0 |
|
|
|
| contig09486 |
---NA--- |
487 |
0 |
|
|
0 |
|
|
|
| contig09487 |
---NA--- |
757 |
0 |
|
|
0 |
|
|
|
| contig09488 |
---NA--- |
209 |
0 |
|
|
0 |
|
|
|
| contig09489 |
glutamic acid and leucine rich protein 1 |
178 |
9 |
8.20E-17 |
66.56% |
3 |
C:cytoplasm; P:transcription; C:nucleus |
|
|
| contig09490 |
glutamic acid and leucine rich protein 1 |
151 |
1 |
1.60E-07 |
75.00% |
0 |
|
|
|
| contig09491 |
low molecular weight phosphotyrosine protein phosphatase |
108 |
20 |
5.31E-11 |
91.00% |
6 |
C:cytoplasm; F:non-membrane spanning protein tyrosine phosphatase activity; F:identical protein binding; C:soluble fraction; F:acid phosphatase activity; P:protein amino acid dephosphorylation |
EC:3.1.3.2 |
|
| contig09492 |
---NA--- |
628 |
0 |
|
|
0 |
|
|
|
| contig09493 |
hexamethylene bis-acetamide inducible 1 |
501 |
20 |
1.84E-54 |
79.00% |
9 |
P:negative regulation of cyclin-dependent protein kinase activity; F:cyclin-dependent protein kinase inhibitor activity; P:heart development; P:negative regulation of transcription from RNA polymerase II promoter; F:protein binding; F:specific transcriptional repressor activity; C:cytoplasm; C:nucleus; F:snRNA binding |
|
|
| contig09494 |
nicotinamide riboside kinase 2 |
1050 |
20 |
4.70E-39 |
87.75% |
5 |
F:kinase activity; P:integrin-mediated signaling pathway; P:pyridine nucleotide biosynthetic process; F:protein binding; F:ATP binding |
|
|
| contig09495 |
cell death-inducing dna fragmentation alpha subunit-like effector a |
785 |
20 |
2.20E-55 |
68.85% |
10 |
P:temperature homeostasis; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:DNA fragmentation involved in apoptosis; P:lipid storage; P:negative regulation of lipid catabolic process; C:mitochondrial envelope; F:protein homodimerization activity; P:negative regulation of apoptosis; C:nucleus; P:cytokine production |
|
|
| contig09496 |
polymerase ii (dna directed) polypeptide d |
973 |
20 |
2.77E-67 |
94.15% |
4 |
F:DNA-directed RNA polymerase activity; C:DNA-directed RNA polymerase II, core complex; P:transcription from RNA polymerase II promoter; F:nucleotide binding |
EC:2.7.7.6 |
|
| contig09497 |
---NA--- |
121 |
0 |
|
|
0 |
|
|
|
| contig09498 |
---NA--- |
457 |
0 |
|
|
0 |
|
|
|
| contig09499 |
eukaryotic translation initiation factor y-linked |
802 |
20 |
2.20E-50 |
98.10% |
8 |
C:eukaryotic translation initiation factor 4F complex; P:translational initiation; F:RNA binding; F:protein binding; P:transport; F:translation initiation factor activity; C:membrane; F:transporter activity |
|
|
| contig09500 |
ww domain containing adaptor with coiled-coil |
469 |
20 |
4.57E-23 |
89.45% |
2 |
C:spliceosomal complex; F:protein binding |
|
|
100 Rows returned.
Helpdesk 